GMCH-32: Newly constructed block to be inaugurated on Aug 8, to decongest gynaecology dept
In the hospital's history, the A Block, where 24-hour emergency services are provided to patients, was the first to become functional, and since 1996, there has been no renovation of this block. 'With the new state-of-the-art trauma block ready for patients, the first step will be to renovate the area, with the engineering and fire safety departments already in action to ensure the latest facilities, amenities and safety.
Once this is complete, we will start the process of decongesting our gynaecology department, which also comprises the labour room, and witnesses patients from across the region, including the large migrant population that we have. We will be utilising this space for the expansion of the department, and also add more beds to ease rush. We are making efforts to provide more speciality and super-speciality services. The process of space creation is a dynamic one,' said Prof A K Attri, Director-Principal, GMCH-32.
The gynaecology department of the hospital has 100 beds, with 10 beds added way back in 2017. The number of patients in the gynaecology department is very high, and despite the increase in beds, there are not enough beds for pregnant women. More than 5,000 women deliver in GMCH every year, and when the number of cases is higher, two women have to be adjusted on one bed, with the occupancy rate almost 200 per cent. The hospital receives delivery cases from Chandigarh, Punjab, Haryana, Himachal, Uttarakhand, UP, and despite the shortage of beds, the effort is to provide treatment. As per doctors, the gynaecology department of GMCH-32 has the highest number of deliveries, followed by GMSH-16 and then PGI.
Both PGI and GMCH-32 will have exclusive Mother and Child Centres, with work on the project of GMCH-32 having started in 2018, but was delayed due to COVID and has now restarted. With a budget of about Rs 73 crore, the centre, which will be open in about two years, will have two basements and four floors and have a facility of 251 beds, with the latest facilities and services under one roof. Dr Attri said it will decrease infant and mother mortality rate.
PGI's Advanced Mother and Child Care Centre, where work is in full swing and may be inaugurated at the end of this year, will be equipped with the latest technologies and offer world-class facilities in both maternal and neonatal care. A human milk bank, advanced infertility treatment, robotic surgery, critical care obstetrics, high-risk maternity unit, foetal medicine unit, pre-implantation genetic diagnosis, prenatal diagnosis, and reproductive endocrinology unit will be part of the centre.
Here, there will be a modern developmentally supportive and family-centred level IV NICU designed as per current International NICU design specifications, a family-centred Kangaroo Mother Care ward, and a comprehensive high-risk follow-up programme.
A long-needed facility, the Advanced Paediatric Centre at GMSH-16 was inaugurated last year. The 32-bedded facility offers state-of-the-art specialised care, featuring a 12-bedded hybrid ICU unit comprising ventilator beds and high-dependency unit beds.
The centre includes 20 oxygen-supported beds and features ECG, echocardiography, and ultrasonography, all under one roof, so that parents don't have to go anywhere for these tests and their children receive the best care. There are 24-hour services like blood transfusion, sample collection, nebulisation etc, for critical patients, and this advanced centre has eased the burden on PGI.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
44 minutes ago
- Indian Express
Chinese man spends over Rs 4.9 crore on salon treatments, suffers diarrhoea and needle wounds
A man from China's Anhui province spent more than 4.3 million yuan (Rs 4.9 crore) over two years at a hair salon for unlicensed detox and wellness services, only to suffer serious health complications and be denied a refund, a local report said. According to the South China Morning Post (SCMP), it all began in April 2023 when Cheng visited a new salon branch in Hefei, the provincial capital. During the launch event, a salon manager invited Cheng inside, where another staff member encouraged him to try a 'beautician's massage.' Cheng told the South China Morning Post that the session turned out to be the start of a persistent and high-pressure sales campaign. He said he was regularly forced to top up his salon account through emotional manipulation. 'They were all young boys and girls, kneeling and saying they were poor and couldn't even afford rent, relying on customers to help support their parents. Older beauticians nearby would consistently urge customers to top up, stating that the staff earned commissions based on performance,' the SCMP quoted Cheng as saying. The salon's offerings included a range of unverified treatments, such as 'skin-breaking needle detox', massages costing 500–600 yuan per body part, and 'belly dampness removal' sessions priced at up to 2,000 yuan. Cheng also underwent multiple enema procedures, marketed as 'bowel cleansing', with one course reportedly priced at 300,000 yuan (Rs 36.2 lakh). While promised results included weight loss and a youthful glow, Cheng said the treatments left him with chronic diarrhoea and unhealed needle wounds. When he discovered that the salon was not licensed to perform medical procedures, he demanded a refund. However, he was turned down. Cheng has since filed a complaint with local authorities. According to SCMP, the Hefei police confirmed on July 9 that a joint investigation with market supervision officials is now underway to probe the salon's alleged illegal medical practices.
Hindustan Times
an hour ago
- Hindustan Times
Indian diplomat visits Syria for meetings with regime led by al-Sharaa
New Delhi: India has made a formal outreach to Syria's provisional government led by former Hay'at Tahrir al-Sham (HTS) leader Ahmed al-Sharaa, with a middle-ranking diplomat visiting Damascus for meetings with Syrian ministers. Syria's interim President Ahmed al-Sharaa. (REUTERS) This was the first official visit to Damascus from the Indian side since al-Sharaa, whose group was once affiliated to al-Qaeda, assumed power after ousting the regime of Bashar al-Assad following a lightning offensive last December. There was no official word from the Indian side on the visit by Suresh Kumar, director of the West Asia and North Africa (WANA) division of the external affairs ministry. Kumar's meetings with Syria's foreign and education ministers in Damascus on Monday were reported by State-run SANA news agency. 'A beginning had to be made and India had to register its presence. You have to open the door at some point,' a person familiar with the matter said on condition of anonymity. Syria's foreign minister Asaad Al-Shaibani and the Indian delegation led by Kumar discussed 'issues of mutual concern and ways of enhancing relations between the two countries in the interests of both peoples', SANA reported. The meeting between Kumar and Syrian health minister Musab Al-Ali focused on enhancing health cooperation, particularly in the fields of pharmaceutical industries and medical training, according to another report by SANA. The two sides also discussed a mechanism for implementing a scholarship for Syrian students, and allocating a specialised engineering cooperation programme for government employees. Al-Ali stressed Syria's aspiration to establish a strong partnership with India in pharmaceutical industries and health technologies in order to support the national health sector and provide medicines. Kumar said India will continue funding specialised training courses for Syrian personnel, coordinate the training of Syrian doctors in Indian centres, and enhance cooperation in nursing, pharmaceutical industries and pharmaceutical exports, the report said. India has had strong political ties with Syria and both countries were key members of the Non-Aligned Movement. India's traditional support for Arab causes such as the issue of Palestine was appreciated by Syria. India also backed Syria's right to the Golan Heights, currently occupied by Israel, and its full return to the country. Under the Assad family, the Syrian government usually backed India at multilateral forums, including on the issue of Kashmir. In response to a request from Damascus for emergency humanitarian aid in 2021, the Indian government gifted 2,000 tonnes of rice to Syria. During the Covid-19 pandemic, India sent 10 tonnes of medicines to Syria. This was the largest medical assistance from any country to Syria during the pandemic. India has been monitoring the situation in Syria since the fall of the Assad regime in December 2024. At the time, India evacuated 77 Indian nationals from Syria. 'We hope that the new constitution, due to be drafted, takes into account the interests of all the sections of the Syrian society,' the external affairs ministry said in a statement around the time of the change of government. In January, al-Sharaa, a former al-Qaeda commander who went by the name Abu Mohammad al-Jolani, became president of the provisional government. People familiar with the matter said the outreach to Damascus was influenced by Syria's strategic location in West Asia – the country shares borders with five key regional actors, Turkey, Iraq, Jordan, Israel and Lebanon – and the long-standing ties between the two sides. The outreach also follows the US decision to end sanctions on Syria after a meeting between al-Sharaa and President Donald Trump in May.
Time of India
2 hours ago
- Time of India
AIIMS experts advocate for robust data, surveillance in India's hepatitis elimination plan
New Delhi: India's hepatitis elimination strategy must prioritise the generation of robust epidemiological data, strengthening integrated surveillance systems, universal access to diagnostics and antivirals and active engagement by the private health sector, said AIIMS experts . In an editorial, 'Hepatitis B virus prevalence in India: A wake-up call for action,' doctors highlighted that despite decades of interventions, HBV remains prevalent, and the progress toward elimination remains slow. According to them, harnessing the momentum of telemedicine expansion initiated during the COVID-19 pandemic, along with decentralised healthcare delivery models, availability of generic antivirals and the use of artificial intelligence for patient management, could significantly enhance hepatitis B virus (HBV) care. The editorial by AIIMS doctors - Dr Shekhar Swaroop and Dr Shalimar of the Department of Gastroenterology and Dr Subrat Kumar Acharya, former HoD of the same department and presently serving as the pro-chancellor at the KIIT University, Bhubaneswar, was published in the Indian Journal of Gastroenterology in June this year. "As the world's most populous nation and a key player in global health, India must prioritise viral hepatitis as a central component of its public health strategy, not only to meet WHO targets, but to protect future generations from this entirely preventable disease," the doctors stated. According to the Global Hepatitis Report 2024, approximately 29.8 million individuals in India were estimated to be living with HBV infection in 2022. The HBV ranked as the third most common cause for cirrhosis, after alcohol and metabolic dysfunction-associated steatotic liver disease. The HBV accounted for approximately 98,305 deaths in India in 2022, reflecting a significant disease burden. Chronic HBV infection confers an increased risk of hepatocellular carcinoma (HCC), and approximately 25 per cent of these individuals will develop HCC during their lifetime. Additionally, HBV reactivation is an acute precipitant of acute on chronic liver failure (ACLF) in around 15% of the patients globally and in 7.7 per cent in South-East Asia, according to a recent meta-analysis, the editorial said. To address this challenge, India launched the National Viral Hepatitis Control Program (NVHCP) in 2018, aiming to reduce the incidence, morbidity and mortality of HBV. Initiatives under this programme include hepatitis B vaccination, universal screening of donated blood and interventions for preventing mother-to-child transmission. "While significant progress has been made, particularly with third-dose hepatitis B vaccine coverage reaching approximately 93% in 2023 and the proportion of children aged 12-23 months receiving all three doses improving from 62.8 per cent (NFHS-4) to 83.9 per cent (NFHS-5), critical gaps still remain," the editorial pointed out. Birth dose vaccination coverage stands at 63 per cent, while the diagnosis rate is 2.4 per cent and treatment coverage rate 0.0 per cent. These figures underscore significant deficiencies in the current response and highlight urgent areas requiring improvement, the doctors stated. Accurate prevalence estimates are essential for guiding public health strategies and resource allocation. In this context, the recent community-based prevalence study by Rajalatchumi et al. from Puducherry represents a valuable contribution. The researchers invited all adults from four villages of rural Puducherry for HbsAg testing, achieving a commendable 94 per cent participation rate. The study found an adjusted prevalence of 2.5 per cent after adjusting for the sensitivity and specificity of the diagnostic test, higher than the NFHS-4 estimate. Interestingly, younger individuals showed a higher infection rate, and blood transfusion remained a risk factor, suggesting ongoing gaps in infection control and awareness, the doctors stated. When compared to a 2013 study from the same region, which reported a prevalence of 2.96 per cent, there was little change over the past decade, pointing to significant gaps in public health strategies and infection control measures, they stated. Despite methodological strengths, the study's generalisability is limited by regional heterogeneity across socio-economic status, transmission risk factors and healthcare access. Nevertheless, this study is a timely and very relevant reminder of the persistent burden of HBV in India, the doctors said. "Despite decades of interventions, HBV remains prevalent and the progress toward elimination remains slow. This is further hindered by limited public awareness, the absence of mandatory screening protocols and limited linkage to care," they said, adding nationally representative population-based surveys are rare and existing surveillance systems remain fragmented and under-resourced. PTI
